The next Virtual BPF Seminar, "Strategies of Detection and Mitigation of Immunogenicity from Peptide Therapeutics", will be held Wednesday, May 22nd starting at 1:00 PM EDT (10:00 AM PDT). We will be hosting Dr. Daniela Verthelyi (Chief of the Immunology Lab in the Office of Pharmaceutical Quality Research at CDER and FDA) and Dr. Brian Roberts (Director of Preclinical Immunology at EpiVax, Inc) who will each present their work on strategies they are using to detect and mitigate immunogenicity response from peptide therapeutics and related impurities. A moderated panel discussion and Q&A session will follow each presentation.
Registration is free, and can be completed at Virtual BPS | Boulder Peptide Symposium. *Note* you must be signed in to the site in order to sign up.
These educational e-seminars are provided free of charge by the Boulder Peptide Foundation. If your company is interested in supporting this or other educational initiatives, please email sponsorship@boulderpeptide.org.
